A total of 36 eyes of 27 patients <18 years of age diagnosed with CNV between January 1978 and December 2008 were retrospectively reviewed. CNV was clinically diagnosed in all patients and its ...

Expert Rev Ophthalmol. 2008;3(3):311-323. The new and promising strategies for treating CNV include the use of drugs against VEGF, in particular isoform A, which is the most potent promoter of ...

Please provide your email address to receive an email when new articles are posted on . A 48-year old white female presented for her annual eye exam through our primary care service. She was severely ...

Please provide your email address to receive an email when new articles are posted on . Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was ...

Intraretinal microvascular abnormalities (IRMAs) are abnormal branching, or dilation, of the blood vessels in the retina. It occurs as a complication of diabetic retinopathy. Diabetic retinopathy ...

November 11, 2008 (Atlanta, Georgia) — GS-101 eye-drop therapy results in a significant regression of corneal neovascularization, whereas treatment with placebo shows an increase in new vessels in all ...

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, Beijing Chaoyang Hospital and the University of Queensland have developed a new formulation based on ...

Specific changes to your eye’s blood vessels can indicate that you have an eye complication of diabetes that needs attention. When you have diabetes, especially for a long time, high blood sugar ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

Diabetic retinopathy is the most severe of the several ocular complications of diabetes. Advances in treatment over the past 40 years have greatly reduced the risk of blindness from this disease, but ...

Corneal neovascularization (CNV) occurs when abnormal blood vessels grow into the cornea in response to ischemic or hypoxic conditions caused by infections, inflammation or chemical injuries.